Target Name: TLN1
NCBI ID: G7094
Other Name(s): talin-1 | Talin 1 | TLN | KIAA1027 | OTTHUMP00000021350 | Talin-1 | ILWEQ | talin 1 | TLN1_HUMAN

TLN1: A Potential Drug Target for Neurodegenerative Diseases

TLN1, or Tau-associated protein 1, is a protein that is expressed in various tissues throughout the body, including the brain, and is known for its role in the development and progression of neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease.

Recent studies have identified TLN1 as a potential drug target for the treatment of these debilitating diseases. By blocking the activity of TLN1, researchers have found that they can reduce the symptoms of neurodegenerative diseases and even reverse some of the damage.

One of the reasons why TLN1 is considered a potential drug target is because it is involved in the formation of neurofibrillary tangles, which are a hallmark of neurodegenerative diseases. These tangles are composed of abnormal aggregates of the protein tau, which are thought to contribute to the destruction of nerve cells in these diseases. By blocking the formation of these tangles, TLN1 has been shown to have the potential to treat neurodegenerative diseases.

Another reason why TLN1 is a promising drug target is because it is involved in the regulation of the blood-brain barrier. This barrier is responsible for controlling the movement of substances into and out of the brain, and is thought to play a role in the development of neurodegenerative diseases. By manipulating the blood-brain barrier, TLN1 has been shown to have the potential to treat certain neurodegenerative diseases.

In addition to its potential as a drug target, TLN1 is also a biomarker for the diagnosis and monitoring of neurodegenerative diseases. This is because its expression is often reduced in the brains of individuals with neurodegenerative diseases, and can be used as a diagnostic marker for these conditions.

Overall, TLN1 is a protein that has the potential to be a drug target for the treatment of neurodegenerative diseases. Its involvement in the formation of neurofibrillary tangles and its role in the regulation of the blood-brain barrier make it a promising target for researchers to explore for new treatments for these debilitating diseases.

Protein Name: Talin 1

Functions: Probably involved in connections of major cytoskeletal structures to the plasma membrane. High molecular weight cytoskeletal protein concentrated at regions of cell-substratum contact and, in lymphocytes, at cell-cell contacts (By similarity)

More Common Targets

TLN2 | TLNRD1 | TLR1 | TLR10 | TLR12P | TLR2 | TLR3 | TLR4 | TLR5 | TLR6 | TLR7 | TLR8 | TLR8-AS1 | TLR9 | TLX1 | TLX1NB | TLX2 | TLX3 | TM2D1 | TM2D2 | TM2D3 | TM4SF1 | TM4SF1-AS1 | TM4SF18 | TM4SF19 | TM4SF19-AS1 | TM4SF19-DYNLT2B | TM4SF20 | TM4SF4 | TM4SF5 | TM6SF1 | TM6SF2 | TM7SF2 | TM7SF3 | TM9SF1 | TM9SF2 | TM9SF3 | TM9SF4 | TMA16 | TMA7 | TMBIM1 | TMBIM4 | TMBIM6 | TMC1 | TMC2 | TMC3 | TMC4 | TMC5 | TMC6 | TMC7 | TMC8 | TMCC1 | TMCC1-DT | TMCC2 | TMCC3 | TMCO1 | TMCO1-AS1 | TMCO2 | TMCO3 | TMCO4 | TMCO5A | TMCO5B | TMCO6 | TMED1 | TMED10 | TMED10P1 | TMED11P | TMED2 | TMED3 | TMED4 | TMED5 | TMED6 | TMED7 | TMED7-TICAM2 | TMED8 | TMED9 | TMEFF1 | TMEFF2 | TMEM100 | TMEM101 | TMEM102 | TMEM104 | TMEM105 | TMEM106A | TMEM106B | TMEM106C | TMEM107 | TMEM108 | TMEM109 | TMEM11 | TMEM114 | TMEM115 | TMEM116 | TMEM117 | TMEM119 | TMEM120A | TMEM120B | TMEM121 | TMEM121B | TMEM123